In section Market Quotes

OncoTherapy Science’s Half-Year Net Loss Widens to ¥574M

OncoTherapy Science Inc. reported a net loss of ¥574 million for the six months ended September 30, 2026, compared with a ¥555 million loss in the same period a year earlier. Revenue fell to ¥335 million from ¥431 million.

By Money Talk·November 6, 2026·2 min read·169 reads

OncoTherapy Science’s Half-Year Net Loss Widens to ¥574M

The Japanese company recorded an operating loss of ¥568 million, against ¥475 million in the prior-year period. Its pretax loss widened to ¥572 million from ¥493 million.

Loss per share narrowed to ¥1.42 from ¥1.89. The results are based on Japanese accounting standards.

OncoTherapy Science’s Half-Year Net Loss Widens to ¥574M

Comments (0)